Komori
Nagaileben (7447) · InitiativeAdvanced

Addressing Rising Costs Through Product Price Revisions

First written in FY2016. 9 of 16 entries say "Advanced", first in FY2017. Latest entry: 2026-10-02.

16entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2023-Q2RestatedFY2024-Q3 – FY20252016: 12017: 120172018: 020182019: 020192020: 020202021: 020212022: 020222023: 420232024: 420242025: 120252026: 52026
Same theme, other companies
Selling Price Revisions Due to Raw Material and Supplier Price IncreasesA theme 121 companies write about · 22 as a headwind · 101 as a tailwind

The whole theme swung hardest in 2020: 2 of 17 companies on the "Worse" side.

69 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 121 companies compared. The sentences above are computed from all 121.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「The price revisions implemented in February have been progressing smoothly.」

    It states that the price revisions pursued since the previous fiscal year were implemented in February and gained traction steadily in the market during the current interim period.
  2. FY2025RestatedAnnual report

    「In addition to further increases in raw-material prices due to inflation and other factors, logistics and personnel costs are rising and the difficult market environment continues. Accordingly, our group plans to implement price revisions in order to continue supplying products on a stable basis.」

    It continues to pursue a policy of implementing price revisions in response to rising raw-material, logistics and personnel costs.
  3. FY2024RestatedAnnual report

    「The gross margin was 42.8%, down 1.1 percentage points year on year, as a result of measures to improve margins, including shifting production overseas and revising prices.」

    It continues to pursue margin-improvement measures combining price revisions with a shift to overseas production and other initiatives, although the full-year gross margin declined year on year.
  4. FY2024-Q3RestatedAnnual report

    「Through the production-shift effect from the higher overseas production ratio and sales price revisions, the gross margin for the cumulative third-quarter consolidated period was 43.2%, limiting the decline to 0.6 percentage points year on year.」

    It continues to use selling-price revisions together with the increase in the overseas production ratio as measures to address rising costs and improve margins.
  5. FY2024-Q2AdvancedAnnual report

    「As a result of the production-shift effect from the higher overseas production ratio and sales price revisions, the gross margin on net sales was 43.2%, up 0.3 percentage points year on year.」

    It reports that the selling-price revisions, together with the increase in the overseas production ratio, contributed to a 0.3-percentage-point year-on-year increase in the gross margin.
  6. FY2024-Q1AdvancedAnnual report

    「As a result of the production-shift effect from the higher overseas production ratio and sales price revisions, the gross margin on net sales was 44.0%, up 1.2 percentage points year on year.」

    It reports that the selling-price revisions pursued since the previous fiscal year, together with the increase in the overseas production ratio, contributed to an improvement in the gross margin.
  7. FY2023ReframedAnnual report

    「Although profit is expected to improve as the price increases gain further traction, a sudden deterioration in the external environment, such as a rapid depreciation of the yen in the foreign exchange market, could have a significant impact on costs.」

    It expects profit to improve as the price increases implemented in February gain traction, while also noting the possibility that the impact on costs could expand due to yen depreciation and other factors.
  8. FY2023-Q3RestatedAnnual report

    「Our group (the Company and its consolidated subsidiaries) implemented price increases from February in response to sharply rising costs. Although the increases have generally been absorbed by the market, price negotiations have taken time for some renewal projects,」

    While the price increases implemented from February have generally been absorbed by the market, price negotiations have taken time for some renewal projects, resulting in timing differences by month.
  9. FY2023-Q2AchievedAnnual report

    「To achieve the full-year consolidated earnings forecast, we are implementing the planned price revisions from February and continuing to strengthen our sales structure and develop the foundations for future growth.」

    The price revisions being advanced toward February 2023 were implemented as planned. Strengthening the sales structure and developing the foundations for future growth are described as ongoing measures.
  10. FY2023-Q1AdvancedAnnual report

    「Regarding production for the consolidated results of the fiscal year ending August 2023, the impact on costs has become apparent due to sudden changes in the external environment, including a sharp rise in raw material prices caused by surging crude oil prices, higher logistics and labor costs, and a rapid depreciation of the yen in foreign exchange markets. In response, we are advancing price revisions and other measures toward February 2023, seeking to minimize their impact in stages and improve profit margins.」

    As a response to higher costs, the company has newly specified time-bound measures, including advancing price revisions toward February 2023.
  11. FY2017AdvancedAnnual report

    「Although domestic processing costs rose and the weaker yen against the US dollar increased costs, the shift of production overseas, the increasing adoption of price revisions and strong sales of new products resulted in a gross margin of 47.5%.」

    The company said that the adoption of price revisions for some products, together with the shift to overseas production and new product sales, contributed to a gross margin of 47.5%.
  12. FY2016First statedAnnual report

    「We implemented price revisions for some products from February.」

    As a concrete response to higher raw material and processing costs, the company implemented price revisions for some products.
Moved together

"Transfer to New Overseas Production Locations and Increase in the Overseas Production Ratio" moved the same way as this thread, in the same document, in 8 of its 16 moves.

877777★123456
  1. ★This thread
  2. 1Transfer to New Overseas Production Locations and Increase in the Overseas Production Ratio8×
  3. 2Steady performance in healthcare wear and doctor wear, with growth in patient wear7×
  4. 3Maintaining Gross Profit Margin at the Previous Year’s Level, with Revenue and Operating Profit Growth7×
  5. 4Treasury Share Acquisitions and Holdings7×
  6. 5Developing Overseas Business with a Focus on East Asia7×
  7. 6The market environment for medical wear remains relatively stable7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nagaileben's next results are scheduled for 2026-10-01. Read the earnings preview It last moved in the Earnings presentation of 2026-10-02: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Addressing Rising Costs Through Product Price Revisions | NAGAILEBEN Co.,Ltd. (7447) | Komori